Table 5: One-year clinical outcome according to SRI subgroups.
|
|
G1 (N = 45) |
G2 (N = 30) |
G3 (N = 43) |
G4 (N = 187) |
|
MACE, n (%) |
6 (13.3) |
4 (13.3) |
5 (11.6) |
10 (5.3) |
|
All-cause death, n (%) |
5 (11.1) |
4 (9.3) |
9 (4.8) |
21 (6.9) |
|
CV death, n (%) |
5 (11.1)* |
2 (6.7) |
4 (9.3) |
6 (3.2) |
|
Non-fatal MI, n (%) |
1 (2.2) |
2 (6.7) |
1 (2.3) |
5 (2.7) |
|
DefiniteST, n (%) |
2 (4.4)* |
2 (6.7) ** |
1 (2.3) |
1 (0.5) |
|
Unplanned revasc., n (%) |
2 (4.4) |
2 (6.7) |
4 (9.3) |
7 (3.7) |
|
TLR, n (%) |
1 (2.2) |
1 (3.3) |
3 (7) |
5 (2.7) |
|
Non-TLR, n (%) |
2 (4.4) |
1 (3.3) |
3 (7) *** |
3 (1.6) |
|
Hospitalization for CV reason, n (%) |
5 (11.1) |
4 (13.3) |
4 (9.3) |
14 (7) |
Abbreviations: CV = Cardiovascular; MACE = Major adverse cardiac events; MI = Myocardial infarction; revasc = Revascularization; ST = Stent thrombosis; SRI = Syntax revascularization index; TLR = Target lesion revascularization. * G1 vs. G4, P < 0.05; ** G2 vs. G4, P < 0.05; *** G3 vs. G4, P < 0.05.